Carcinoid Heart Disease.

Area of Science:

• Cardiology
• Oncology
• Endocrinology

Background:

• Carcinoid heart disease (CHD) is a rare cardiac complication linked to advanced neuroendocrine tumors (NETs) and carcinoid syndrome.
• NETs, particularly small bowel tumors, are most commonly associated with CHD.
• Carcinoid syndrome involves serotonin release, causing flushing, diarrhea, bronchospasm, and heart failure symptoms.

Purpose of the Study:

• To highlight the challenges in managing carcinoid heart disease.
• To emphasize the need for a collaborative, multidisciplinary approach in managing CHD.
• To underscore the importance of quantifying disease burden and delaying valvular disease progression.

Main Methods:

• Review of existing literature on carcinoid heart disease and carcinoid syndrome.
• Analysis of the typical presentation and progression of CHD.
• Discussion of the collaborative care model involving multiple medical specialties.

Main Results:

• CHD prognosis is poor, often less than a year for untreated advanced heart failure patients.
• Late presentation and rapid progression complicate CHD management.
• Multidisciplinary collaboration is essential for effective patient management.

Conclusions:

• Optimal management of CHD requires a coordinated team effort.
• Strategies focus on quantifying disease burden, slowing valvular disease, and tailoring treatment.
• Improving quality of life and reducing mortality are key goals in CHD care.